Royal Bank Of Canada Burning Rock Biotech LTD Transaction History

Royal Bank Of Canada

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$1.73 - $2.95 $25 - $44	15 New	15 $0
Q1 2022 May 16, 2022	SELL	$6.7 - $10.23 $1,494 - $2,281	-223 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$9.43 - $17.14 $2,055 - $3,736	218 Added 4360.0%	223 $2,000
Q3 2021 Nov 15, 2021	BUY	$17.37 - $27.92 $69 - $111	4 Added 400.0%	5 $0
Q2 2021 Aug 16, 2021	BUY	$26.14 - $37.45 $26 - $37	1 New	1 $0

21.2K

Ticker BNR
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 105,188,000
Market Cap $642M
Description
Burning Rock Biotech Limited primarily develops and provides cancer therapy selection tests in the People's Republic of China. It operates in three segments: Central Laboratory Business, In-Hospital Business, and Pharma Research and Development Services. The company primarily offers next-generation sequencing-based cancer therapy selection and p...

Get notified when there are updates to the investment portfolio of Royal Bank Of Canada, based on Form 13F filings with the SEC.

Stay updated on Royal Bank Of Canada with notifications on news.